Ppd Inc Revenue Growth Rates (PPD), Current and Historic Growth - CSIMarket
CSIMarket
 


Ppd Inc   (NASDAQ: PPD)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

PPD's Revenue Growth by Quarter and Year

Ppd Inc 's Revenue results by quarter and year




PPD Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December -
3rd Quarter September 1,560.80
2nd Quarter June 1,575.47
1st Quarter March 1,378.38
FY 4,514.65





PPD Revenue third quarter 2021 Y/Y Growth Comment
Ppd Inc achieved in the third quarter 2021, above Company average Revenue growth of 26.5% year on year, to $ 1,560.80 millions.

Looking into third quarter 2021 results within Medical Laboratories industry 23 other companies have achieved higher Revenue growth. While Ppd Inc ' s Revenue rise of 26.5% ranks overall at the positon no. 1652 in the third quarter 2021.




PPD Revenue ( Y/Y Growth %) 2021
2020 2019 2018
4th Quarter December - 30.32 % 6.97 % -
3rd Quarter September 26.5 % 20.5 % 12.83 % -
2nd Quarter June 55.85 % 1.44 % 9.44 % -
1st Quarter March 28.53 % 11.28 % 1.19 % -
FY   - 16.14 % 7.52 % -

Financial Statements
Ppd Inc 's third quarter 2021 Revenue $ 1,560.80 millions PPD's Income Statement
Ppd Inc 's third quarter 2020 Revenue $ 1,233.80 millions Quarterly PPD's Income Statement


PPD Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
4th Quarter December - 10.58 % 2.25 % 7.85 %
3rd Quarter September -0.93 % 22.05 % 2.74 % -0.34 %
2nd Quarter June 14.3 % -5.74 % 3.4 % -4.4 %
1st Quarter March 1.03 % 2.44 % -1.52 % -
FY (Year on Year)   - 16.14 % 7.52 % -




Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #24
Healthcare Sector #265
Overall #1652

Revenue Y/Y Growth Statistics
High Average Low
55.85 % 18.62 % 1.19 %
(Jun 30 2021)   (Sep 30 2021)
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #24
Healthcare Sector #265
Overall #1652
Revenue Y/Y Growth Statistics
High Average Low
55.85 % 18.62 % 1.19 %
(Jun 30 2021)   (Sep 30 2021)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Ppd Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
22.05 % 3.84 % -5.74 %
(Sep 30 2020)  


PPD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Ppd Inc disclosed decrease in Revenue from the second quarter by -0.93% to $ 1,560.80 millions, from $ 1,575.47 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2021 Revenue, this plainly could not be substantial to rescue Medical Laboratories's company achievement, Most analysts pointed out.

Within Medical Laboratories industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Ppd Inc 's Revenue growth quarter on quarter, overall rank is 3147.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #31
Healthcare Sector #470
Overall #3147
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #31
Healthcare Sector #470
Overall #3147
Revenue Q/Q Growth Statistics
High Average Low
22.05 % 3.84 % -5.74 %
(Sep 30 2020)  


PPD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Ppd Inc disclosed decrease in Revenue from the second quarter by -0.93% to $ 1,560.80 millions, from $ 1,575.47 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2021 Revenue, this plainly could not be substantial to rescue Medical Laboratories's company achievement, Most analysts pointed out.

Within Medical Laboratories industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Ppd Inc 's Revenue growth quarter on quarter, overall rank is 3147.


Ppd Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Revenue 12 Months Ending $ 5,878.94 $ 5,551.95 $ 4,987.39 $ 4,681.47 $ 4,364.07
Y / Y Revenue Growth (TTM) 34.71 % 33.65 % 20.48 % 16.14 % 10.13 %
Year on Year Revenue Growth Overall Ranking # 2245 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 5.89 % 11.32 % 6.53 % 7.27 % 5.05 %
Seq. Revenue Growth (TTM) Overall Ranking # 2668 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 34.71% annual Revenue growth, Ppd Inc would report a record annual Revenue rise if the fiscal year would end on Sep 30 2021.

In the Healthcare sector 340 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2245.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 31
Healthcare Sector # 341
Overall # 2245

Revenue TTM Y/Y Growth Statistics
High Average Low
34.71 %
17.59 %
7.52 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 379
S&P 500 # 2668
Cumulative Revenue growth Comment
With 34.71% annual Revenue growth, Ppd Inc would report a record annual Revenue rise if the fiscal year would end on Sep 30 2021.

In the Healthcare sector 340 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2245.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 31
Healthcare Sector # 341
Overall # 2245

Revenue TTM Y/Y Growth Statistics
High Average Low
34.71 %
17.59 %
7.52 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 31
Sector # 379
S&P 500 # 2668




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PPD's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2021
Electromedical Technologies Inc 46.28%$ 46.285 millions
Aerie Pharmaceuticals Inc 45.97%$ 45.974 millions
Epizyme Inc.45.85%$ 45.850 millions
Biolase Inc 45.76%$ 45.756 millions
Tandem Diabetes Care Inc 45.33%$ 45.326 millions
Acutus Medical Inc 45.00%$ 45.005 millions
Mannkind Corporation44.68%$ 44.678 millions
Butterfly Network Inc 44.26%$ 44.262 millions
Tela Bio Inc 44.06%$ 44.062 millions
American Shared Hospital Services43.77%$ 43.774 millions
Htg Molecular Diagnostics Inc41.83%$ 41.827 millions
Iradimed Corporation41.67%$ 41.670 millions
Caredx Inc 41.63%$ 41.635 millions
T2 Biosystems Inc 41.62%$ 41.621 millions
Optinose Inc 41.40%$ 41.397 millions
Global Blood Therapeutics Inc.41.10%$ 41.104 millions
Somalogic Inc 40.46%$ 40.462 millions
Kymera Therapeutics Inc 39.93%$ 39.930 millions
Jazz Pharmaceuticals Plc39.48%$ 39.479 millions
Rxsight Inc 38.75%$ 38.753 millions
Avita Medical Inc 38.74%$ 38.735 millions
Nexgel Inc 38.43%$ 38.430 millions
Align Technology inc 38.38%$ 38.380 millions
Immucell Corporation38.35%$ 38.352 millions
Kala Bio inc 38.15%$ 38.153 millions
Vivos Therapeutics Inc 38.11%$ 38.107 millions
Precipio inc 38.05%$ 38.045 millions
Palvella Therapeutics Inc 38.04%$ 38.040 millions
Co diagnostics Inc 37.96%$ 37.961 millions
Electrocore Inc 37.59%$ 37.587 millions


About Ppd Inc Revenue Growth Rates (PPD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.